RESMED, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 217 USD | -0.54% |
|
-0.50% | +26.14% |
| Apr. 26 | Sector Update: Health Care Stocks Edge Higher Late Afternoon | MT |
| Apr. 26 | Top Midday Gainers | MT |
Presentation Operator MessageOperator (Operator)Hello, and welcome to the Q3 Fiscal Year 2024 ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Calendar
2024-05-07
- Ex-dividend day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
217
USD
Average target price
216.6
USD
Spread / Average Target
-0.15%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +26.14% | 31.88B | |
| +7.84% | 218B | |
| +7.35% | 184B | |
| +13.04% | 135B | |
| -1.33% | 62.38B | |
| +11.80% | 51.37B | |
| +4.81% | 50.9B | |
| +0.30% | 40.87B | |
| +2.78% | 36.28B | |
| +18.76% | 24.39B |
- Stock Market
- Equities
- RMD Stock
- News ResMed, Inc.
- Transcript : ResMed Inc., Q3 2024 Earnings Call, Apr 25, 2024
